EE354 Budget Impact Analysis of Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis in the UK
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.600
https://www.valueinhealthjournal.com/article/S1098-3015(22)02804-2/fulltext
Title :
EE354 Budget Impact Analysis of Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02804-2&doi=10.1016/j.jval.2022.09.600
First page :
Section Title :
Open access? :
No
Section Order :
10133